Morgan Stanley maintains Willis Towers Watson at Equal-Weight, raises price target to $350 from $325

Morgan Stanley kept Willis Towers Watson at Equal-Weight and raised its price target to $350 from $325. The new target implies 4.4% upside versus the Nov 13 close of $335.34. Other analysts’ targets in the past month ranged from $360 to $397.

Original reporting
Published Nov 16, 2026, 4:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 4:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley maintains Willis Towers Watson at Equal-Weight, raises price target to $350 from $325 — source image
Decision brief

The 30-second read

$WTWBullishLow
01

Why it matters

For traders, the actionable element is the specific price-target increase and the implied upside versus the referenced Nov 13 close; however, there is no new company-specific fundamental information.

02

Market read

A modest bullish analyst update for WTW, likely to influence near-term sentiment but not a standalone fundamental catalyst.

03

What to watch

The article does not provide the thesis behind the target raise, nor does it indicate any new Willis Towers Watson catalyst that could drive a larger repricing.

Relevance 4/10Novelty 4/10Timing: as of the analyst note update, no scheduled event cited

Background

The piece summarizes Morgan Stanley’s rating and price-target update for Willis Towers Watson and notes the recent spread of analyst targets over the prior month.

Company-level read

Ticker impact

$WTWBullishMedium confidence
Context

Morgan Stanley maintained Willis Towers Watson at Equal-Weight and raised its price target to $350 from $325, implying upside from the Nov 13 close.

Expected impact

Likely mild upward pressure or support as traders price in the higher target, though follow-through depends on broader analyst consensus.

Evidence & confidence

The article provides a specific target change and implied upside, but no new Willis Towers Watson operational or financial datapoint.

Market effects

Limited sector read-through; this is a single-name analyst target change in insurance/consulting services.

None indicated.

None indicated.

Counterpoint

The move may be incremental within a broader range of recent targets, so it may not change positioning materially.

Key entities

  • Willis Towers Watson

    Morgan Stanley maintained an Equal-Weight rating and raised its price target to $350 from $325.

  • Morgan Stanley

    Issued the rating maintenance and price-target increase referenced in the article.

Related articles

$WTWMed

Willis Re wraps up BMS Re US acquisition

Willis Re completed its acquisition of BMS Re US, expanding its US reinsurance operations and adding capabilities in complex property and casualty risks. The deal includes BMS Intermediaries and BMS Capital Advisory, and was announced in August 2026. Financial terms were not disclosed. Willis Re aims to grow its platform and enhance client value with the acquisition.

$WTWMed

Mizuho raises Willis Towers Watson stock price target on valuation

Mizuho raised its price target on Willis Towers Watson (WTW) to $370 from $349, maintaining an Outperform rating. The stock trades at $324.42, suggesting 14% upside. Mizuho lowered earnings estimates but kept them above consensus. WTW reported Q3 2026 organic growth of 4%, meeting expectations, and exceeded Wall Street's earnings and revenue forecasts. Goldman Sachs and Raymond James also maintained positive ratings with higher price targets.

$WTWHighAI 9/10

What Willis Towers Watson Public (WTW) Said on Its Q3 Earnings Call

Willis Towers Watson (WTW) reported Q3 earnings, with Risk & Broking revenue up 5% organically, driven by North America and international growth. Insurance Consulting and Technology grew 2%, with technology demand strong but consulting revenue down. WTW maintained its outlook for mid-single-digit organic growth and margin expansion. The company is investing in AI initiatives under its Propel plan, expecting $350 million in net run-rate savings by 2028.